Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
LivaNova
LIVN
$4.2B
| $20.7M | 0.01% |
393,418
-407,984
| -51% | -$20.2M |
|
1052
iShares US Transportation ETF
IYT
$2.29B
| $20.5M | 0.01% |
297,319
+97,319
| +49% | +$6.41M |
|
1053
Mohawk Industries
MHK
$9.21B
| $20.5M | 0.01% |
127,462
+1,801
| +1% | +$259K |
|
1054
FMC
FMC
$1.33B
| $20.5M | 0.01% |
310,378
+45,752
| +17% | +$2.8M |
|
1055
PUT
VanEck Semiconductor ETF
SMH
$73.2B
| $20.4M | 0.01% |
+83,000
| New | +$20.2M |
|
1056
PUT
Applied Materials
AMAT
$428B
| $20.4M | 0.01% |
+100,800
| New | +$20.7M |
|
1057
Guardant Health
GH
$22.6B
| $20.3M | 0.01% |
887,031
+409,659
| +86% | +$11.6M |
|
1058
Patterson-UTI
PTEN
$3.77B
| $20.2M | 0.01% |
2,644,634
+8,347
| +0.3% | +$76.9K |
|
1059
BioMarin Pharmaceuticals
BMRN
$12.3B
| $20.2M | 0.01% |
287,591
-830,789
| -74% | -$69.4M |
|
1060
Aecom
ACM
$9.75B
| $20.1M | 0.01% |
194,949
-56,871
| -23% | -$5.34M |
|
1061
PUT
Broadcom
AVGO
$2.03T
| $20.1M | 0.01% |
+116,700
| New | +$18.7M |
|
1062
PUT
ON Semiconductor
ON
$19.3B
| $20.1M | 0.01% |
+276,900
| New | +$20.2M |
|
1063
Antero Midstream
AM
$10.1B
| $20.1M | 0.01% |
1,334,762
-226,746
| -15% | -$3.3M |
|
|
SKX
1064
CALL
DELISTED
Skechers
SKX
| $20.1M | 0.01% |
+300,000
| New | +$19.7M |
|
1065
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $20M | 0.01% |
202,500
-455,000
| -69% | -$44.7M |
|
1066
Cytokinetics
CYTK
$10.4B
| $19.9M | 0.01% |
376,996
+94,618
| +34% | +$5.27M |
|
1067
Manhattan Associates
MANH
$11.4B
| $19.9M | 0.01% |
70,557
-31,077
| -31% | -$7.91M |
|
1068
Samsara
IOT
$23.8B
| $19.8M | 0.01% |
412,066
+255,532
| +163% | +$10.4M |
|
1069
CALL
Aptiv
APTV
$10.3B
| $19.8M | 0.01% |
275,000
-538,900
| -66% | -$37.6M |
|
|
EXE
1070
Expand Energy Corp
EXE
$21.5B
| $19.8M | 0.01% |
240,696
-538,690
| -69% | -$41.1M |
|
|
GES
1071
DELISTED
Guess Inc
GES
| $19.8M | 0.01% |
983,279
-261,387
| -21% | -$5.55M |
|
|
SCHW
1072
CALL
Charles Schwab
SCHW
$187B
| $19.7M | 0.01% |
304,700
-938,400
| -75% | -$61.6M |
|
1073
PUT
Arhaus
ARHS
$1.36B
| $19.7M | 0.01% |
+1,604,000
| New | +$21.7M |
|
1074
LKQ Corp
LKQ
$6.29B
| $19.7M | 0.01% |
493,418
-97,161
| -16% | -$4M |
|
1075
CALL
Oracle
ORCL
$423B
| $19.6M | 0.01% |
115,300
-119,100
| -51% | -$17.3M |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.